Year_NN
to_PIN
Year_NN
to_PIN
31_CD
December_NN
2002_CD
31_CD
December_NN
2001_CD
Notes_NN
000_CD
000_CD
Turnover_NN
2_CD
69,573_CD
46,126_CD
Cost_NN
of_PIN
sales_NN
2_CD
24,830_CD
18,820_CD
Gross_NN
profit_NN
44,743_CD
27,306_CD
Selling_GER
,_,
marketing_GER
and_PHC
distribution_NOMZ
expenses_NN
4,769_CD
4,804_CD
Administration_NOMZ
expenses_NN
Amortisation_NOMZ
6,506_CD
3,824_CD
Other_JJ
administration_NOMZ
expenses_NN
13,686_CD
12,201_CD
20,192_CD
16,025_CD
Research_NN
and_PHC
development_NOMZ
expenses_NN
29,285_CD
17,918_CD
Other_JJ
operating_GER
income_NN
3_CD
14,219_CD
6,342_CD
Operating_GER
profit_NN
loss_NN
2,4_CD
4,716_CD
5,099_CD
Associated_NN
undertaking_GER
Share_NN
of_PIN
loss_NN
of_PIN
associated_VBN
undertaking_GER
75_CD
Amortisation_NOMZ
of_PIN
goodwill_NN
503_CD
578_CD
Total_JJ
operating_GER
profit_NN
loss_NN
:_:
Group_NN
and_PHC
share_NN
of_PIN
associates_NN
4,716_CD
5,677_CD
Interest_NN
receivable_NN
6_CD
1,081_CD
1,251_CD
Interest_NN
payable_JJ
7_CD
4,464_CD
4,951_CD
Profit_NN
loss_NN
on_PIN
ordinary_JJ
activities_NOMZ
before_IN
taxation_NOMZ
1,333_CD
9,377_CD
Taxation_NOMZ
8_CD
224_CD
75_CD
Retained_VBN
profit_NN
loss_NN
1,109_CD
9,452_CD
Earnings_GER
per_PIN
Ordinary_NN
Share_NN
9_CD
Basic_JJ
0.2_CD
p_NN
1.8_CD
p_NN
Diluted_NN
0.2_CD
p_NN
1.8_CD
p_NN
There_EX
was_VBD
no_SYNE
material_NN
difference_NN
between_PIN
the_DT
profit_NN
loss_NN
on_PIN
ordinary_JJ
activities_NOMZ
before_IN
taxation_NOMZ
and_CC
the_DT
historical_JJ
cost_NN
profit_NN
loss_NN
before_IN
taxation_NOMZ
in_PIN
2002_CD
and_CC
2001_CD
._.
All_QUAN
results_NN
represent_VPRT
continuing_VBG
activities_NOMZ
._.
See_VB [PRIV]
Notes_NN
to_PIN
the_DT
Financial_NN
Statements_NOMZ
consolidated_JJ
profit_NN
50_CD
and_CC
loss_NN
account_NN
SkyePharma_NN
annual_JJ
report_NN
2002_CD
